DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Buse JB, Rosenstock J, Sesti G. et al.
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a
26-week randomised, parallel-group, multinational, open-label trial
(LEAD-6).
Lancet 2009;
374: 39-47
We do not assume any responsibility for the contents of the web pages of other providers.